Another strategy is the generation of CAR-T cells expressing enzymes against tumor stroma (e.g., heparanase) or chemokine receptors (e.g., CXCR1 and CXCR2) matching tumor chemokines and promoting infiltration [17,62]. This evidence concerns the gene CXCR1 and neoplasm.